Quintrio
Home

PHARMACEUTICAL PREPARATIONS

Vogenx Inc Common Stock

VOGX

Vogenx Inc is a clinical-stage biopharmaceutical company focused on the discovery and development of novel therapies for the treatment of serious diseases associated with dysfunctions in human metabolism, including post-bariatric hypoglycemia, or PBH, and gastroparesis. The company's flagship product candidate, mizagliflozin, is an orally administered, minimally absorbed, small molecule drug candidate being developed for the treatment of post-bariatric hypoglycemia (PBH), gastroparesis and GIP-induced Cushing's Syndrome. It operates as a single reportable segment engaged in the discovery and development of treatments for serious metabolic and gastrointestinal diseases.

Last trade $13.61
Day change -$0.77 (-5.35%)
Day range $12.84 – $15.36
Volume 56,410
Market cap $214M

Open XNAS

Fundamentals

Key company ratios and reported financial statements.

Source: Massive.com

Key ratios

No ratio data was found for VOGX.

Financial statements

Income and cash flow amounts are for the period; balance sheets are point-in-time snapshots. Amounts are shown in USD. Latest 8 quarterly or 5 annual periods are displayed when available.

Income statement for VOGX, quarterly periods
Line itemQ3 FY2026 Sep 30, 2026
Revenue$0
Cost of revenue$0
Gross profit$0
Selling, general and administrative$703.74K
Research and development$1.08M
Total operating expenses$1.78M
Operating income-$1.78M
Interest expense$0
Income before taxes-$4.91M
Income taxes$0
Net income-$4.91M
Net income attributable to common shareholders-$4.91M
EBITDA-$1.78M
Basic earnings per share-$0.47
Diluted earnings per share-$0.47

Recent news

Company coverage with links to the original publishers.

Publication times in UTC

No recent company news found.

Dividends

Declared distributions and recorded event dates. Forecasts are not shown.

Updated daily

No declared upcoming dividend found.

No prior dividend records found.

Stock splits

Historical share-structure events and their execution dates.

Updated daily

No stock split records found.